Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

JPM PEER ANALYSIS

JPMorgan Chase & Co — metric-by-metric comparison with peers and the industry median

JPMJPMorgan Chase & Co

🇺🇸 USA · US · Financial Services · Banks - Diversified

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Banks - Diversified

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
JPMIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
JPM+16.8%RY+66.6%SAN+75.6%TD+73.5%CBA-5.5%BBVA+78.7%
Year-to-Date (YTD)
JPM+4.8%RY+25.8%SAN+24.8%TD+33.6%CBA+4.1%BBVA+16.4%
1-Year
Split-adjusted
JPM+16.8%BAC+23.2%WFC+6.1%C+65.0%BNY+62.2%
Year-to-Date (YTD)
JPM+4.8%BAC+7.9%WFC-7.3%C+21.1%BNY+27.4%

Key Metric Comparison

P/E

Lower is better
JPM16.15RY18.66SAN11.28TD19.49CBA—BBVA11.91Median 14.62

ROE

Higher is better
JPM16.5%RY16.2%SAN15.6%TD11.9%CBA—BBVA19.4%Median 12.1%

Net Margin

Higher is better
JPM20.7%RY18.4%SAN18.3%TD13.2%CBA—BBVA27.7%Median 17.3%

Revenue Growth

Higher is better

P/E

Lower is better
JPM16.15BAC14.16WFC13.31C16.92BNY17.17Median 14.62

ROE

Higher is better
JPM16.5%BAC10.6%WFC12.1%C7.6%BNY13.6%Median 12.1%

Net Margin

Higher is better
JPM20.7%BAC18.1%WFC17.3%C9.3%BNY14.7%Median 17.3%

Revenue Growth

Higher is better

All Metrics

Valuation
MetricJPMRYSANTDCBABBVAInd. Median
P/E16.1518.6611.28●19.49—11.9114.62
P/B2.572.881.72●2.283.582.291.81
EV/EBITDA3.6230.9321.5625.75—-3.86●19.44
P/S———————
Financial Health
MetricJPMRYSANTDCBABBVAInd. Median
Current Ratio0.624.42●0.120.280.090.440.44
Debt/Equity338.8%277.3%409.1%556.9%268.6%155.6%●294.1%
NetDebt/EBITDA-7.5213.9013.3511.96—-10.95●8.47
Profitability
MetricJPMRYSANTDCBABBVAInd. Median
Net Margin20.7%18.4%18.3%13.2%—27.7%●17.3%
ROE16.5%16.2%15.6%11.9%—19.4%●12.1%
ROA1.3%1.0%0.9%0.7%—1.3%●0.7%
EBITDA Margin———————
Growth + Dividend
MetricJPMRYSANTDCBABBVAInd. Median
Rev. Growth———————
NI Growth-1.3%21.5%23.1%●-14.2%—2.4%12.5%
Div. Yield1.8%2.2%2.0%2.5%3.1%4.1%●2.8%
Payout29.2%41.6%20.7%52.0%—38.8%40.2%
Valuation
MetricJPMBACWFCCBNYInd. Median
P/E16.1514.1613.31●16.9217.1714.62
P/B2.571.451.541.18●2.291.81
EV/EBITDA3.6213.453.4036.99-10.54●19.44
P/S——————
Financial Health
MetricJPMBACWFCCBNYInd. Median
Current Ratio0.62●0.540.340.050.570.44
Debt/Equity338.8%127.6%252.6%355.1%118.9%●294.1%
NetDebt/EBITDA-7.523.16-4.8327.55-21.46●8.47
Profitability
MetricJPMBACWFCCBNYInd. Median
Net Margin20.7%●18.1%17.3%9.3%14.7%17.3%
ROE16.5%●10.6%12.1%7.6%13.6%12.1%
ROA1.3%●0.9%1.0%0.6%1.2%0.7%
EBITDA Margin——————
Growth + Dividend
MetricJPMBACWFCCBNYInd. Median
Rev. Growth——————
NI Growth-1.3%13.8%8.7%19.5%26.2%●12.5%
Div. Yield1.8%1.9%2.0%●1.7%1.4%2.8%
Payout29.2%30.4%30.1%33.8%28.6%40.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on JPM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.